Deep vein thrombosis
366 results
335 - 366
Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction): Cochrane systematic review- Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders: Cochrane systematic review
- Anticoagulants versus antiplatelet agents for acute ischaemic stroke: Cochrane systematic review
- Antifibrinolytic drugs for acute traumatic injury: Cochrane systematic review
- Cell salvage for minimising perioperative allogeneic blood transfusion in adults undergoing elective surgery
- Endovenous ablation therapy (laser or radiofrequency) or foam sclerotherapy versus conventional surgical repair for short saphenous varicose veins: Cochrane systematic review
- Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures
- Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism
- Parenteral anticoagulation in ambulatory patients with cancer
- Continuous versus intermittent physiological monitoring for acute stroke: Cochrane systematic review
Tranexamic acid for preventing postpartum haemorrhage - Compression therapy for treating post‐thrombotic syndrome
- Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity
- Pedicle screw fixation for traumatic fractures of the thoracic and lumbar spine: Cochrane systematic review
- Dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation
- Arthroscopic surgery for degenerative knee disease (osteoarthritis including degenerative meniscal tears)
- Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure
- Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases
- Neuromuscular electrical stimulation for the prevention of venous thromboembolism
- Oral anticoagulation in people with cancer who have no therapeutic or prophylactic indication for anticoagulation
- Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
- Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism
- Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
- Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery
- Very early versus delayed mobilisation after stroke
- Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease
- Effect of testing for cancer on cancer‐ or venous thromboembolism (VTE)‐related mortality and morbidity in people with unprovoked VTE
- Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
- Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews
- Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta‐analysis
- Treatments for Morton's neuroma
- Antithrombotic therapy for ambulatory patients with multiple myeloma receiving immunomodulatory agents